Form 8-K - Current report:
SEC Accession No. 0001437749-25-018482
Filing Date
2025-05-27
Accepted
2025-05-27 16:05:33
Documents
15
Period of Report
2025-05-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K sava20250523_8k.htm   iXBRL 8-K 51496
2 EXHIBIT 10.1 ex_823543.htm EX-10.1 19833
7 logo01.jpg GRAPHIC 16250
  Complete submission text file 0001437749-25-018482.txt   238558

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sava-20250523.xsd EX-101.SCH 3579
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sava-20250523_def.xml EX-101.DEF 12190
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE sava-20250523_lab.xml EX-101.LAB 16408
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sava-20250523_pre.xml EX-101.PRE 12460
17 EXTRACTED XBRL INSTANCE DOCUMENT sava20250523_8k_htm.xml XML 3086
Mailing Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731
Business Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731 512-501-2444
CASSAVA SCIENCES INC (Filer) CIK: 0001069530 (see all company filings)

EIN.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41905 | Film No.: 25988094
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)